- Home
- CLWT vs IBIO Comparison
CLWT vs IBIO Comparison
Compare CLWT & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLWT
- IBIO
- Stock Information
- Founded
- CLWT 1971
- IBIO 2008
- Country
- CLWT Hong Kong
- IBIO United States
- Employees
- CLWT N/A
- IBIO N/A
- Industry
- CLWT Professional and commerical equipment
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CLWT Consumer Discretionary
- IBIO Health Care
- Exchange
- CLWT Nasdaq
- IBIO Nasdaq
- Market Cap
- CLWT 8.9M
- IBIO 9.3M
- IPO Year
- CLWT 1997
- IBIO N/A
- Fundamental
- Price
- CLWT $1.29
- IBIO $0.73
- Analyst Decision
- CLWT
- IBIO Strong Buy
- Analyst Count
- CLWT 0
- IBIO 3
- Target Price
- CLWT N/A
- IBIO $4.87
- AVG Volume (30 Days)
- CLWT 201.6K
- IBIO 2.3M
- Earning Date
- CLWT 04-30-2025
- IBIO 05-02-2025
- Dividend Yield
- CLWT 6.18%
- IBIO N/A
- EPS Growth
- CLWT N/A
- IBIO N/A
- EPS
- CLWT 0.10
- IBIO N/A
- Revenue
- CLWT $15,383,000.00
- IBIO $375,000.00
- Revenue This Year
- CLWT N/A
- IBIO $36.00
- Revenue Next Year
- CLWT N/A
- IBIO N/A
- P/E Ratio
- CLWT $13.35
- IBIO N/A
- Revenue Growth
- CLWT N/A
- IBIO 650.00
- 52 Week Low
- CLWT $1.01
- IBIO $0.64
- 52 Week High
- CLWT $1.94
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- CLWT 55.14
- IBIO 24.07
- Support Level
- CLWT $1.12
- IBIO $0.75
- Resistance Level
- CLWT $1.57
- IBIO $0.82
- Average True Range (ATR)
- CLWT 0.13
- IBIO 0.14
- MACD
- CLWT 0.02
- IBIO 0.10
- Stochastic Oscillator
- CLWT 50.00
- IBIO 3.04
About CLWT Euro Tech Holdings Company Limited
Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.